Metabolic plasticity is an essential requirement of acquired tyrosine kinase inhibitor resistance in Chronic myeloid leukemia 

Contreras Mostazo, Miriam Guadalupe; Kurrle, Nina; Casado, Marta; Fuhrmann, Dominik; Alshamleh, Islam; Häupl, Björn; Martín Sanz, Paloma; Brüne, Bernhard, 1957-; Serve, Hubert; Schwalbe, Harald; Schnütgen, Frank; Marín Martínez, Silvia; Cascante i Serratosa, Marta (2021-03-02)

Tyrosine kinase inhibitors (TKIs) are currently the standard chemotherapeutic agents for the treatment of chronic myeloid leukemia (CML). However, due to TKI resistance acquisition in CML patients, identification of new ...